| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 2 | 8 | 622 | 226 | - | - | - | 858 |
| - | - | - | - | - | 2 | 1 | - | - | - | 3 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| 546 |
| 62 |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 1,424 |
| 673 |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(R) | 858 | 28.4% | -8.16 | 3 | 0.3% |
| PLP(R) | 732 | 24.2% | -6.71 | 7 | 0.7% |
| PLP(L) | 339 | 11.2% | 0.13 | 371 | 39.4% |
| CentralBrain-unspecified | 342 | 11.3% | -0.21 | 295 | 31.3% |
| AME(R) | 466 | 15.4% | -inf | 0 | 0.0% |
| Optic-unspecified(L) | 112 | 3.7% | 0.64 | 174 | 18.5% |
| AME(L) | 80 | 2.6% | -0.37 | 62 | 6.6% |
| Optic-unspecified(R) | 78 | 2.6% | -4.70 | 3 | 0.3% |
| ME(L) | 8 | 0.3% | 1.70 | 26 | 2.8% |
| LH(R) | 9 | 0.3% | -inf | 0 | 0.0% |
| PVLP(L) | 2 | 0.1% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns MeVPaMe2 | % In | CV |
|---|---|---|---|---|---|
| aMe5 (L) | 25 | ACh | 515 | 17.7% | 0.6 |
| aMe5 (R) | 16 | ACh | 336 | 11.5% | 0.7 |
| aMe30 (R) | 2 | Glu | 201 | 6.9% | 0.2 |
| MeTu3b (R) | 27 | ACh | 132 | 4.5% | 0.7 |
| MeVC20 (R) | 2 | Glu | 127 | 4.4% | 0.1 |
| aMe10 (L) | 1 | ACh | 116 | 4.0% | 0.0 |
| Mi15 (R) | 64 | ACh | 111 | 3.8% | 0.6 |
| MeVP5 (R) | 9 | ACh | 102 | 3.5% | 0.5 |
| Mi10 (R) | 40 | ACh | 101 | 3.5% | 0.7 |
| Cm20 (R) | 13 | GABA | 87 | 3.0% | 0.7 |
| MeVP3 (R) | 19 | ACh | 82 | 2.8% | 0.9 |
| MeVP10 (R) | 23 | ACh | 81 | 2.8% | 0.8 |
| MeVP21 (R) | 3 | ACh | 67 | 2.3% | 0.1 |
| aMe6b (R) | 1 | ACh | 55 | 1.9% | 0.0 |
| aMe24 (R) | 1 | Glu | 52 | 1.8% | 0.0 |
| MeVP12 (R) | 14 | ACh | 50 | 1.7% | 0.5 |
| aMe10 (R) | 2 | ACh | 48 | 1.6% | 0.2 |
| MeTu1 (R) | 20 | ACh | 45 | 1.5% | 0.8 |
| Cm11d (R) | 5 | ACh | 44 | 1.5% | 0.7 |
| MeVP5 (L) | 8 | ACh | 37 | 1.3% | 0.5 |
| aMe12 (R) | 2 | ACh | 30 | 1.0% | 0.2 |
| aMe30 (L) | 3 | Glu | 25 | 0.9% | 0.7 |
| MeVP31 (R) | 1 | ACh | 22 | 0.8% | 0.0 |
| aMe26 (R) | 3 | ACh | 22 | 0.8% | 0.3 |
| aMe1 (L) | 2 | GABA | 18 | 0.6% | 0.9 |
| Cm-DRA (R) | 3 | ACh | 16 | 0.5% | 0.1 |
| MeTu3a (R) | 10 | ACh | 16 | 0.5% | 0.5 |
| PLP129 (R) | 1 | GABA | 13 | 0.4% | 0.0 |
| MeVPMe11 (L) | 1 | Glu | 12 | 0.4% | 0.0 |
| aMe4 (R) | 5 | ACh | 12 | 0.4% | 0.6 |
| aMe6c (R) | 1 | Glu | 11 | 0.4% | 0.0 |
| mALD1 (L) | 1 | GABA | 11 | 0.4% | 0.0 |
| Cm3 (R) | 9 | GABA | 11 | 0.4% | 0.3 |
| Cm30 (R) | 2 | GABA | 10 | 0.3% | 0.4 |
| Dm2 (R) | 6 | ACh | 10 | 0.3% | 0.3 |
| Cm31a (R) | 1 | GABA | 9 | 0.3% | 0.0 |
| AOTU056 (R) | 2 | GABA | 9 | 0.3% | 0.3 |
| AOTU056 (L) | 2 | GABA | 8 | 0.3% | 0.5 |
| Cm12 (R) | 6 | GABA | 8 | 0.3% | 0.6 |
| aMe12 (L) | 4 | ACh | 8 | 0.3% | 0.4 |
| LoVCLo3 (L) | 1 | OA | 7 | 0.2% | 0.0 |
| aMe2 (L) | 3 | Glu | 7 | 0.2% | 0.5 |
| OA-AL2i3 (L) | 2 | OA | 7 | 0.2% | 0.1 |
| LoVCLo3 (R) | 1 | OA | 6 | 0.2% | 0.0 |
| Cm14 (R) | 4 | GABA | 6 | 0.2% | 0.3 |
| MeVP9 (R) | 4 | ACh | 6 | 0.2% | 0.3 |
| MeLo6 (R) | 6 | ACh | 6 | 0.2% | 0.0 |
| Cm31b (R) | 1 | GABA | 5 | 0.2% | 0.0 |
| MeLo3b (R) | 2 | ACh | 5 | 0.2% | 0.6 |
| MeVP1 (R) | 5 | ACh | 5 | 0.2% | 0.0 |
| MeVC20 (L) | 1 | Glu | 4 | 0.1% | 0.0 |
| LoVP11 (R) | 1 | ACh | 4 | 0.1% | 0.0 |
| MeVP31 (L) | 1 | ACh | 4 | 0.1% | 0.0 |
| aMe9 (R) | 1 | ACh | 4 | 0.1% | 0.0 |
| MeVP43 (R) | 1 | ACh | 4 | 0.1% | 0.0 |
| Dm-DRA1 (R) | 3 | Glu | 4 | 0.1% | 0.4 |
| Cm9 (R) | 3 | Glu | 4 | 0.1% | 0.4 |
| MeLo1 (R) | 3 | ACh | 4 | 0.1% | 0.4 |
| MeVP7 (R) | 3 | ACh | 4 | 0.1% | 0.4 |
| PLP084 (R) | 1 | GABA | 3 | 0.1% | 0.0 |
| MeVP22 (R) | 1 | GABA | 3 | 0.1% | 0.0 |
| LHPD5a1 (R) | 1 | Glu | 3 | 0.1% | 0.0 |
| aMe22 (R) | 1 | Glu | 3 | 0.1% | 0.0 |
| aMe15 (R) | 1 | ACh | 3 | 0.1% | 0.0 |
| MeVC22 (L) | 1 | Glu | 3 | 0.1% | 0.0 |
| OA-AL2i3 (R) | 1 | OA | 3 | 0.1% | 0.0 |
| Lat3 (R) | 2 | unc | 3 | 0.1% | 0.3 |
| KCg-d (R) | 2 | DA | 3 | 0.1% | 0.3 |
| MeVP15 (R) | 2 | ACh | 3 | 0.1% | 0.3 |
| MeVPLo2 (R) | 2 | ACh | 3 | 0.1% | 0.3 |
| aMe9 (L) | 2 | ACh | 3 | 0.1% | 0.3 |
| MeVP12 (L) | 3 | ACh | 3 | 0.1% | 0.0 |
| MeLo1 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| TmY18 (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| AOTU055 (R) | 1 | GABA | 2 | 0.1% | 0.0 |
| OCG02c (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| HBeyelet (R) | 1 | HA | 2 | 0.1% | 0.0 |
| LHPV4c3 (R) | 1 | Glu | 2 | 0.1% | 0.0 |
| SLP171 (R) | 1 | Glu | 2 | 0.1% | 0.0 |
| LoVP44 (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| aMe17b (R) | 1 | GABA | 2 | 0.1% | 0.0 |
| MeVP36 (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| MeVC23 (R) | 1 | Glu | 2 | 0.1% | 0.0 |
| OA-AL2i4 (R) | 1 | OA | 2 | 0.1% | 0.0 |
| SMP091 (R) | 2 | GABA | 2 | 0.1% | 0.0 |
| CB3050 (R) | 2 | ACh | 2 | 0.1% | 0.0 |
| SMP217 (L) | 2 | Glu | 2 | 0.1% | 0.0 |
| MeTu2a (R) | 2 | ACh | 2 | 0.1% | 0.0 |
| MeTu3c (R) | 2 | ACh | 2 | 0.1% | 0.0 |
| MeVP14 (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| Cm25 (R) | 2 | Glu | 2 | 0.1% | 0.0 |
| PLP149 (R) | 2 | GABA | 2 | 0.1% | 0.0 |
| MeVC21 (L) | 2 | Glu | 2 | 0.1% | 0.0 |
| Tm_unclear (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVPMe10 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeTu3b (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| CL014 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| aMe23 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| aMe22 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| CL357 (L) | 1 | unc | 1 | 0.0% | 0.0 |
| aMe6b (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| SMP238 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| Tm5c (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| Tm39 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| aMe_unclear (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| Cm18 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| R7d | 1 | HA | 1 | 0.0% | 0.0 |
| MeLo5 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| Cm8 (R) | 1 | GABA | 1 | 0.0% | 0.0 |
| MeVP11 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Tm1 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| Cm_unclear (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeTu2b (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| CB1467 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP14 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| LHPV2g1 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| PLP174 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVPMe9 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| Cm-DRA (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| LC41 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| Lawf1 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| SLP223 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| aMe2 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| PLP261 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| LHPD1b1 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVP4 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Cm11b (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| PLP231 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP1 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP39 (R) | 1 | GABA | 1 | 0.0% | 0.0 |
| PLP231 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| CL352 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| Cm28 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| aMe24 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| PLP080 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| 5-HTPMPV01 (L) | 1 | 5-HT | 1 | 0.0% | 0.0 |
| LoVP58 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP32 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| aMe3 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVP33 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| aMe15 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Cm33 (R) | 1 | GABA | 1 | 0.0% | 0.0 |
| LoVP96 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVP28 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| LT58 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVP56 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| aMe4 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| LoVP53 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVC22 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVPaMe1 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVPMe3 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| l-LNv (R) | 1 | unc | 1 | 0.0% | 0.0 |
| MeVC3 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| aMe17c (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| LoVC20 (R) | 1 | GABA | 1 | 0.0% | 0.0 |
| MeVPMe12 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| OA-VUMa6 (M) | 1 | OA | 1 | 0.0% | 0.0 |
| MeVPMe2 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| OA-VUMa3 (M) | 1 | OA | 1 | 0.0% | 0.0 |
| downstream partner | # | NT | conns MeVPaMe2 | % Out | CV |
|---|---|---|---|---|---|
| aMe30 (L) | 3 | Glu | 191 | 11.2% | 0.2 |
| aMe17e (L) | 1 | Glu | 182 | 10.7% | 0.0 |
| MeVC22 (L) | 2 | Glu | 130 | 7.6% | 0.0 |
| aMe8 (L) | 2 | unc | 83 | 4.9% | 0.2 |
| LoVP53 (L) | 1 | ACh | 71 | 4.2% | 0.0 |
| Lat1 (L) | 4 | unc | 71 | 4.2% | 0.3 |
| LoVP54 (L) | 1 | ACh | 63 | 3.7% | 0.0 |
| DNpe021 (L) | 1 | ACh | 60 | 3.5% | 0.0 |
| aMe6a (L) | 1 | ACh | 47 | 2.8% | 0.0 |
| aMe_TBD1 (L) | 1 | GABA | 44 | 2.6% | 0.0 |
| aMe3 (L) | 1 | Glu | 41 | 2.4% | 0.0 |
| aMe15 (L) | 1 | ACh | 41 | 2.4% | 0.0 |
| CL125 (L) | 2 | Glu | 41 | 2.4% | 0.1 |
| aMe1 (L) | 1 | GABA | 39 | 2.3% | 0.0 |
| aMe_unclear (L) | 1 | Glu | 32 | 1.9% | 0.0 |
| CL063 (L) | 1 | GABA | 30 | 1.8% | 0.0 |
| MeVC21 (L) | 3 | Glu | 25 | 1.5% | 0.4 |
| LoVP96 (L) | 1 | Glu | 23 | 1.4% | 0.0 |
| MeVP63 (L) | 1 | GABA | 22 | 1.3% | 0.0 |
| LPLC2 (L) | 8 | ACh | 20 | 1.2% | 0.5 |
| MeVC20 (L) | 2 | Glu | 18 | 1.1% | 0.4 |
| AOTU056 (L) | 2 | GABA | 18 | 1.1% | 0.1 |
| MeTu3b (L) | 3 | ACh | 18 | 1.1% | 0.4 |
| Pm13 (L) | 1 | Glu | 17 | 1.0% | 0.0 |
| AOTU058 (L) | 4 | GABA | 17 | 1.0% | 0.8 |
| MeVP33 (L) | 1 | ACh | 16 | 0.9% | 0.0 |
| MeVP39 (L) | 1 | GABA | 13 | 0.8% | 0.0 |
| SMP200 (L) | 1 | Glu | 13 | 0.8% | 0.0 |
| MeVP29 (L) | 1 | ACh | 12 | 0.7% | 0.0 |
| LC6 (L) | 5 | ACh | 12 | 0.7% | 0.3 |
| aMe5 (L) | 8 | ACh | 12 | 0.7% | 0.5 |
| PLP174 (L) | 2 | ACh | 11 | 0.6% | 0.1 |
| MeVPaMe1 (L) | 1 | ACh | 10 | 0.6% | 0.0 |
| Cm20 (L) | 2 | GABA | 9 | 0.5% | 0.3 |
| Lat2 (L) | 2 | unc | 9 | 0.5% | 0.3 |
| aMe4 (L) | 4 | ACh | 9 | 0.5% | 0.6 |
| l-LNv (L) | 1 | unc | 8 | 0.5% | 0.0 |
| PLP094 (L) | 1 | ACh | 8 | 0.5% | 0.0 |
| LoVCLo3 (L) | 1 | OA | 7 | 0.4% | 0.0 |
| LoVCLo3 (R) | 1 | OA | 7 | 0.4% | 0.0 |
| aMe6c (L) | 2 | Glu | 7 | 0.4% | 0.1 |
| LoVP38 (L) | 1 | Glu | 6 | 0.4% | 0.0 |
| SLP250 (L) | 1 | Glu | 6 | 0.4% | 0.0 |
| Cm8 (L) | 2 | GABA | 6 | 0.4% | 0.7 |
| Tm5c (L) | 2 | Glu | 6 | 0.4% | 0.3 |
| MeVP21 (L) | 2 | ACh | 6 | 0.4% | 0.3 |
| DNp27 (L) | 1 | ACh | 5 | 0.3% | 0.0 |
| LoVP12 (L) | 1 | ACh | 5 | 0.3% | 0.0 |
| LC36 (L) | 1 | ACh | 5 | 0.3% | 0.0 |
| MeVPaMe2 (L) | 1 | Glu | 5 | 0.3% | 0.0 |
| SLP322 (L) | 2 | ACh | 5 | 0.3% | 0.6 |
| aMe2 (L) | 4 | Glu | 5 | 0.3% | 0.3 |
| aMe23 (L) | 1 | Glu | 4 | 0.2% | 0.0 |
| SMP530_a (L) | 1 | Glu | 4 | 0.2% | 0.0 |
| MeTu3c (L) | 2 | ACh | 4 | 0.2% | 0.5 |
| aMe12 (L) | 2 | ACh | 4 | 0.2% | 0.5 |
| SMP192 (L) | 1 | ACh | 3 | 0.2% | 0.0 |
| aMe13 (L) | 1 | ACh | 3 | 0.2% | 0.0 |
| SMP201 (L) | 1 | Glu | 3 | 0.2% | 0.0 |
| PLP211 (L) | 1 | unc | 3 | 0.2% | 0.0 |
| CL365 (L) | 1 | unc | 3 | 0.2% | 0.0 |
| LoVC19 (L) | 1 | ACh | 3 | 0.2% | 0.0 |
| MeVP14 (L) | 2 | ACh | 3 | 0.2% | 0.3 |
| MeTu1 (L) | 3 | ACh | 3 | 0.2% | 0.0 |
| MeVP3 (R) | 3 | ACh | 3 | 0.2% | 0.0 |
| PLP130 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| aMe22 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| SLP295 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| MeLo6 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| SMP217 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| OCG02c (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| Dm-DRA1 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| LC10c-1 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| PLP085 (R) | 1 | GABA | 2 | 0.1% | 0.0 |
| PLP084 (R) | 1 | GABA | 2 | 0.1% | 0.0 |
| MeVP12 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| PS272 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| Cm24 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| 5thsLNv_LNd6 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| AVLP571 (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| aMe17b (L) | 1 | GABA | 2 | 0.1% | 0.0 |
| DNp101 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| 5-HTPMPV01 (R) | 1 | 5-HT | 2 | 0.1% | 0.0 |
| MeVPMe11 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| OA-AL2i3 (L) | 1 | OA | 2 | 0.1% | 0.0 |
| aMe4 (R) | 2 | ACh | 2 | 0.1% | 0.0 |
| aMe17c (R) | 2 | Glu | 2 | 0.1% | 0.0 |
| aMe17c (L) | 2 | Glu | 2 | 0.1% | 0.0 |
| MeVC23 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP7 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP6 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP17 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| SLP267 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeLo7 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| AOTU055 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeVP1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Lat3 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| Lat3 (R) | 1 | unc | 1 | 0.1% | 0.0 |
| LHPV2g1 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeTu3b (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVP73 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm14 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| Cm11d (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm11b (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP069 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| aMe23 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| LHPV1d1 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| CL234 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Lat4 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| CL086_a (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe10 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVPLo2 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| LoVP26 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP144 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeVP42 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| AN09B023 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Lat5 (L) | 1 | unc | 1 | 0.1% | 0.0 |
| LoVP100 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| MeVP25 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Pm12 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| CL086_e (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe30 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| Mi19 (R) | 1 | unc | 1 | 0.1% | 0.0 |
| MeVPaMe1 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| aMe20 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm30 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeVP56 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP23 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVP49 (R) | 1 | Glu | 1 | 0.1% | 0.0 |
| MeVC3 (L) | 1 | ACh | 1 | 0.1% | 0.0 |
| PLP079 (L) | 1 | Glu | 1 | 0.1% | 0.0 |
| LoVC4 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeVP53 (L) | 1 | GABA | 1 | 0.1% | 0.0 |